Wallace Advisory Group’s CVS Health CVS Stock Holding History

Wallace Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$410K	Sell	3,960 -805	-17%	-$71.9K	0.39%	69
2026 Q1	$342K	Buy	4,765 +539	+13%	+$41.5K	0.37%	64
2025 Q4	$335K	Sell	4,226 -3,257	-44%	-$257K	0.35%	78
2025 Q3	$516K	Sell	7,483 -2,350	-24%	-$161K	0.41%	70
2025 Q2	$666K	Buy	9,833 +988	+11%	+$64.8K	0.48%	52
2025 Q1	$397K	Buy	8,845 +1,236	+16%	+$74K	0.27%	107
2024 Q4	$478K	Buy	7,609 +132	+2%	+$7.41K	0.33%	85
2024 Q3	$442K	Sell	7,477 -264	-3%	-$15.4K	0.32%	83
2024 Q2	$457K	Buy	+7,741	New	+$484K	0.33%	81

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wallace Advisory Group's CVS Position: Q2 2026 in Review

Wallace Advisory Group reduced its CVS Health (CVS) stake by 17% in Q2 2026, selling an estimated $71.9K and leaving 3,960 shares worth $410K. The position accounts for 0.39% of the portfolio, ranked #69.

Wallace Advisory Group first reported a position in CVS in Q2 2024 and has held it in 9 quarters since. The position peaked at $666K in Q2 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Wallace Advisory Group held 3,960 shares of CVS Health worth $410K as of Q2 2026.
Wallace Advisory Group sold 805 CVS Health shares in Q2 2026, an estimated $71.9K.
CVS Health made up 0.39% of Wallace Advisory Group's portfolio in Q2 2026, its #69 holding.
Wallace Advisory Group first reported a position in CVS Health in Q2 2024 and has held it in 9 quarters since.
Wallace Advisory Group's CVS Health position peaked at $666K in Q2 2025.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Wallace Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.